Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Dobbeltdiagnoser og død

    Project: Types of projectsProject

  1. Traumatic brain injury and dementia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Electroconvulsive therapy and risk of dementia in patients with affective disorders: a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Male fertility before and after androgen abuse

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Detection of illness worry in the general population: A specific item on illness rumination improves the Whiteley Index

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: People with severe mental illness have both increased mortality and are more likely to have a substance use disorder. We assessed the association between mortality and lifetime substance use disorder in patients with schizophrenia, bipolar disorder, or unipolar depression.

METHODS: In this prospective, register-based cohort study, we obtained data for all people with schizophrenia, bipolar disorder, or unipolar depression born in Denmark in 1955 or later from linked nationwide registers. We obtained information about treatment for substance use disorders (categorised into treatment for alcohol, cannabis, or hard drug misuse), date of death, primary cause of death, and education level. We calculated hazard ratios (HRs) for all-cause mortality and subhazard ratios (SHRs) for cause-specific mortality associated with substance use disorder of alcohol, cannabis, or hard drugs. We calculated standardised mortality ratios (SMRs) to compare the mortality in the study populations to that of the background population.

FINDINGS: Our population included 41 470 people with schizophrenia, 11 739 people with bipolar disorder, and 88 270 people with depression. In schizophrenia, the SMR in those with lifetime substance use disorder was 8·46 (95% CI 8·14-8·79), compared with 3·63 (3·42-3·83) in those without. The respective SMRs in bipolar disorder were 6·47 (5·87-7·06) and 2·93 (2·56-3·29), and in depression were 6·08 (5·82-6·34) and 1·93 (1·82-2·05). In schizophrenia, all substance use disorders were significantly associated with increased risk of all-cause mortality, both individually (alcohol, HR 1·52 [95% CI 1·40-1·65], p<0·0001; cannabis, 1·24 [1·04-1·48], p=0·0174; hard drugs, 1·78 [1·56-2·04], p<0·0001) and when combined. In bipolar disorder or depression, only substance use disorders of alcohol (bipolar disorder, HR 1·52 [95% CI 1·27-1·81], p<0·0001; depression, 2·01 [1·86-2·18], p<0·0001) or hard drugs (bipolar disorder, 1·89 [1·34-2·66], p=0·0003; depression, 2·27 [1·98-2·60], p<0·0001) increased risk of all-cause mortality individually.

INTERPRETATION: Mortality in people with mental illness is far higher in individuals with substance use disorders than in those without, particularly in people who misuse alcohol and hard drugs. Mortality-reducing interventions should focus on patients with a dual diagnosis and seek to prevent or treat substance use disorders.

FUNDING: The Lundbeck Foundation.

Original languageEnglish
JournalThe Lancet. Psychiatry
Volume2
Issue number9
Pages (from-to)801-8
Number of pages8
ISSN2215-0366
DOIs
Publication statusPublished - Sep 2015

ID: 45824419